» Articles » PMID: 39949983

Redefining DNA Cleavage in Type I CRISPR Systems with the HNH Domain

Overview
Journal MedComm (2020)
Specialty Health Services
Date 2025 Feb 14
PMID 39949983
Authors
Affiliations
Soon will be listed here.
References
1.
Hu C, Ni D, Nam K, Majumdar S, McLean J, Stahlberg H . Allosteric control of type I-A CRISPR-Cas3 complexes and establishment as effective nucleic acid detection and human genome editing tools. Mol Cell. 2022; 82(15):2754-2768.e5. PMC: 9357151. DOI: 10.1016/j.molcel.2022.06.007. View

2.
Zhang C, Chen F, Wang F, Xu H, Xue J, Li Z . Mechanisms for HNH-mediated target DNA cleavage in type I CRISPR-Cas systems. Mol Cell. 2024; 84(16):3141-3153.e5. DOI: 10.1016/j.molcel.2024.06.033. View

3.
Hirano S, Altae-Tran H, Kannan S, Macrae R, Zhang F . Structural determinants of DNA cleavage by a CRISPR HNH-Cascade system. Mol Cell. 2024; 84(16):3154-3162.e5. PMC: 11459484. DOI: 10.1016/j.molcel.2024.07.026. View

4.
Altae-Tran H, Kannan S, Suberski A, Mears K, Demircioglu F, Moeller L . Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering. Science. 2023; 382(6673):eadi1910. PMC: 10910872. DOI: 10.1126/science.adi1910. View

5.
Makarova K, Wolf Y, Iranzo J, Shmakov S, Alkhnbashi O, Brouns S . Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol. 2019; 18(2):67-83. PMC: 8905525. DOI: 10.1038/s41579-019-0299-x. View